Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Throughout the study, there were no significant changes in serum iPTH, calcium, phosphorus, and 25‐hydroxycholecalciferol within each group (Table 3).
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Double-blind reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Effects of Synbiotic Supplementation on Bone Turnover Markers in Kidney Transplant Recipients: A Randomized Controlled Trial
Source: Article title.
This study was a randomized, double‐blind, placebo‐controlled trial, taking place from December 2023 to May 2024.
Source: Methods.
Participants were categorized according to their diabetes status and serum creatinine levels before being randomly allocated to either a synbiotic group or a placebo group.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effects of Synbiotic Supplementation on Bone Turnover Markers in Kidney Transplant Recipients: A Randomized Controlled Trial
Randomised controlled trial · Food Science & Nutrition · 2026
Original publication title
Effects of Synbiotic Supplementation on Bone Turnover Markers in Kidney Transplant Recipients: A Randomized Controlled Trial
© 2026 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
ABSTRACT
Bone disorders are common in kidney transplant (KT) recipients. This research explores the impact of synbiotic supplementation on markers related to bone turnover in these patients. In a randomized controlled trial, 46 KT recipients were allocated at random to either a synbiotic group or a placebo group. Those in the synbiotic group received two capsules daily for a duration of 12 weeks, while the placebo group was given an equivalent placebo. The study measured several bone resorption markers, including C‐telopeptide and receptor activator of nuclear factor kappa B ligand (RANKL), as well as serum levels of the bone formation marker osteocalcin and the bone resorption inhibitor osteoprotegerin.
The findings revealed that serum levels of C‐telopeptide were significantly lower in the synbiotic group compared to the placebo group (p = 0.014). There was a significant increase in osteocalcin levels within the synbiotic group compared to the placebo group (p = 0.041). Serum concentrations of RANKL and osteoprotegerin decreased significantly in both the synbiotic and placebo groups compared to baseline. However, the change in serum concentrations of RANKL and osteoprotegerin did not show a significant difference between the two groups.
Throughout the study period, no significant changes were observed in serum iPTH, calcium, phosphorus, or 25‐hydroxycholecalciferol levels within each group. In conclusion, synbiotic supplementation decreases serum C‐telopeptide, a marker of bone resorption, and increases serum osteocalcin, a marker of bone formation, in KT recipients.
Authors’ abstract
ABSTRACT
Bone disorders are common in kidney transplant (KT) recipients. This research explores the impact of synbiotic supplementation on markers related to bone turnover in these patients. In a randomized controlled trial, 46 KT recipients were allocated at random to either a synbiotic group or a placebo group. Those in the synbiotic group received two capsules daily for a duration of 12 weeks, while the placebo group was given an equivalent placebo. The study measured several bone resorption markers, including C‐telopeptide and receptor activator of nuclear factor kappa B ligand (RANKL), as well as serum levels of the bone formation marker osteocalcin and the bone resorption inhibitor osteoprotegerin.
The findings revealed that serum levels of C‐telopeptide were significantly lower in the synbiotic group compared to the placebo group (p = 0.014). There was a significant increase in osteocalcin levels within the synbiotic group compared to the placebo group (p = 0.041). Serum concentrations of RANKL and osteoprotegerin decreased significantly in both the synbiotic and placebo groups compared to baseline. However, the change in serum concentrations of RANKL and osteoprotegerin did not show a significant difference between the two groups.
Throughout the study period, no significant changes were observed in serum iPTH, calcium, phosphorus, or 25‐hydroxycholecalciferol levels within each group. In conclusion, synbiotic supplementation decreases serum C‐telopeptide, a marker of bone resorption, and increases serum osteocalcin, a marker of bone formation, in KT recipients.
Publication and source details
Original title: Effects of Synbiotic Supplementation on Bone Turnover Markers in Kidney Transplant Recipients: A Randomized Controlled Trial
Zeinab Karimi; Hadi Tabibi; Mohsen Nafar; Shiva Samavat; Ahmad Firouzan; Mehdi Hedayati
Food Science & Nutrition · 2026
* Correspondence:Hadi Tabibi (hadtabibi@yahoo.com; tabibi@sbmu.ac.ir)
© 2026 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:07:19.749397+00:00
DOI: 10.1002/fsn3.72117 · PMC13369291